DGX vs TEM · P/E 22, rev $9.87B vs rev $1.27B
Quest Diagnostics Incorporated (DGX) versus Tempus AI, Inc. Class A Common Stock (TEM) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Tempus AI, Inc. Class A Common Stock (TEM) is a health information services company listed on NASDAQ.
Latest reported DGX revenue for 2024-12-31 was $9.87B. Net income was $921.0M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported TEM revenue for 2025-12-31 was $1.27B. Net income was -$245.0M. Revenue was up 83.4% from 2024-12-31 to 2025-12-31. TEM currently screens at market cap $8.76B.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. TEM currently screens at market cap $8.76B.
Not investment advice. Open the DGX and TEM stock pages for the full models.
Not investment advice.